Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

1WUA

The structure of Aplyronine A-actin complex

Summary for 1WUA
Entry DOI10.2210/pdb1wua/pdb
DescriptorActin, alpha skeletal muscle, CALCIUM ION, ADENOSINE-5'-TRIPHOSPHATE, ... (5 entities in total)
Functional Keywordsaplyronine a, macrolide, potent antitumor effect, marine sponge, structural protein
Biological sourceOryctolagus cuniculus (rabbit)
Cellular locationCytoplasm, cytoskeleton: P68135
Total number of polymer chains1
Total formula weight43499.34
Authors
Hirata, K.,Muraoka, S.,Suenaga, K.,Kuroda, T.,Kato, K.,Tanaka, H.,Yamamoto, M.,Takata, M.,Yamada, K.,Kigoshi, H. (deposition date: 2004-12-03, release date: 2006-02-14, Last modification date: 2023-10-25)
Primary citationHirata, K.,Muraoka, S.,Suenaga, K.,Kuroda, T.,Kato, K.,Tanaka, H.,Yamamoto, M.,Takata, M.,Yamada, K.,Kigoshi, H.
Structure basis for antitumor effect of aplyronine a
J.Mol.Biol., 356:945-954, 2006
Cited by
PubMed Abstract: Aplyronine A, isolated from the sea hare Aplysia kurodai, possesses an exceedingly potent antitumor effect in vivo and it is one of the promising candidates as an anticancer drug. This macrolide is known to depolymerize F-actin and inhibit the polymerization of actin by forming a 1:1 complex with monomeric actin. The first complex structure of actin-aplyronine A was determined via a synchrotron X-ray analysis at a 1.45 A resolution. As expected, aplyronine A binds to a hydrophobic cleft composed of subdomains 1 and 3 of actin by intercalating its aliphatic tail part into the actin molecule as do the other reported F-actin depolymerizing agents. Unexpectedly, this complex structure shows the specific structural features around the trimethylserine moiety, revealed as an important moiety of aplyronine A for cytotoxicity against HeLa cells. Combining this result and our previous one, the moiety should strongly relate to the specific biological activity of aplyronine A; i.e. a potent antitumor effect.
PubMed: 16406066
DOI: 10.1016/j.jmb.2005.12.031
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.45 Å)
Structure validation

237423

PDB entries from 2025-06-11

PDB statisticsPDBj update infoContact PDBjnumon